PuSH - Publication Server of Helmholtz Zentrum München: Critical role of TGF-β and IL-2 receptor signalling in Foxp3 inducion by an inhibitor of DNA methylation.

Information

Clues to quality of journals

Open Access Policy of Helmholtz Association 2016

CC Licencences

Publication Metrics

Navigation

Home

Deutsch

EVA: Electronic Publishing

New EVA Application

Research

Advanced Search

Browse by ...

... HMGU-Authors/Consortia

... Organizational Structure

... Journal

... Publication Type

... Research Data

... Arbeitsgruppen

... Publication Year

Publication overview

Statistics

Statistics (last 5 years)

OA Publications

Publish

Submit Publication

Import publication from...

...EVA

Report missing publication

Highlights

Support & Contact

Contact persons

Help

Data protection

Helmholtz Open Science

JANE Journal Estimator

SHERPA/RoMEO

DOAJ

Export:

Text

Endnote (RIS) BIB

BibTeX

Freudenberg, K.* ; Lindner, N.* ; Dohnke, S.* ; Garbe, A.I.* ; Schallenberg, S.* ; Kretschmer, K.

Critical role of TGF-β and IL-2 receptor signalling in Foxp3 inducion by an inhibitor of DNA methylation.

Front. Immunol. 9, DOI: 10.3389/fimmu.2018.00125 (2018)

Publ. Version/Full Text

Research data

DOI

PMC

	Open Access Gold

Abstract
Metrics
Extra information

Under physiological conditions, CD4(+) regulatory T (Treg) cells expressing the transcription factor Foxp3 are generated in the thymus [thymus-derived Foxp3(+) Treg (tTregs) cells] and extrathymically at peripheral sites [peripherally induced Foxp3(+) Treg (pTreg) cell], and both developmental subsets play non-redundant roles in maintaining self-tolerance throughout life. In addition, a variety of experimental in vitro and in vivo modalities can extrathymically elicit a Foxp3(+) Treg cell phenotype in peripheral CD4(+) Foxp3(-) T cells, which has attracted much interest as an approach toward cell-based therapy in clinical settings of undesired immune responses. A particularly notable example is the in vitro induction of Foxp3 expression and Treg cell activity (iTreg cells) in initially naive CD4(+)Foxp3(-) T cells through T cell receptor (TCR) and IL-2R ligation, in the presence of exogenous TGF-beta. Clinical application of Foxp3(+) iTreg cells has been hampered by the fact that TGF-beta-driven Foxp3 induction is not sufficient to fully recapitulate the epigenetic and transcriptional signature of in vivo induced Foxp3(+) tTreg and pTreg cells, which includes the failure to imprint iTreg cells with stable Foxp3 expression. This hurdle can be potentially overcome by pharmacological interference with DNA methyltransferase activity and CpG methylation [e.g., by the cytosine nucleoside analog 5-aza-2'-deoxycytidine (5-aza-dC)] to stabilize TGF-beta-induced Foxp3 expression and to promote a Foxp3(+) iTreg cell phenotype even in the absence of added TGF-beta. However, the molecular mechanisms of 5-aza-dC-mediated Foxp3(+) iTreg cell generation have remained incompletely understood. Here, we show that in the absence of exogenously added TGF-beta and IL-2, efficient 5-aza-dC-mediated Foxp3+ iTreg cell generation from TCR-stimulated CD4(+) Foxp3(-) T cells is critically dependent on TGF-beta R and IL-2R signaling and that this process is driven by TGF-beta and IL-2, which could either be FCS derived or produced by T cells on TCR stimulation. Overall, these findings contribute to our understanding of the molecular mechanisms underlying the process of Foxp3 induction and may provide a rational basis for generating phenotypically and functionally stable iTreg cells.

Impact Factor

Scopus SNIP

Web of Science
Times Cited

Scopus
Cited By

Altmetric

5.511

1.484